Aligos Therapeutics Inc
(ALGS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 70,103 | 24,547 | N/A | N/A |
| Marketable Securities | 48,098 | 66,817 | N/A | N/A |
| Other current assets | 2,025 | 1,005 | 0 | 0 |
| TOTAL | $120,226 | $92,369 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 8,517 | 2,878 | N/A | N/A |
| Investments And Advances | 10,019 | 0 | 0 | 0 |
| Other Non-Current Assets | 7,758 | 12,484 | 0 | 0 |
| TOTAL | $26,294 | $15,362 | $N/A | $N/A |
| Total Assets | $146,520 | $107,731 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 3,767 | 2,977 | 0 | 0 |
| Accrued Expenses | 7,599 | 3,258 | N/A | N/A |
| TOTAL | $13,818 | $7,489 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 197,415 | 113,964 | 0 | 0 |
| TOTAL | $197,593 | $113,990 | $N/A | $N/A |
| Total Liabilities | $211,411 | $121,479 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -66,197 | -13,933 | N/A | N/A |
| Other shareholders' equity | -115 | 3 | 0 | 0 |
| TOTAL | $-64,891 | $-13,748 | $N/A | $N/A |
| Total Liabilities And Equity | $146,520 | $107,731 | $0 | $0 |